Haematology Horizon Medical Masterclass 2024: Beyond the data, enhancing patient care through collaboration

18 May, 2024 | London


Beyond the data: Enhancing patient care through collaboration is a face-to-face meeting designed to empower and equip HCPs with practical strategies to optimise patient care within their clinic and support their professional development. Through expert presentations, immersive case scenarios and interactive workshops, we will explore how shared decision making and strengthened collaboration among HCPs can enhance patient-centric care.

Please see below for a summary of the meeting agenda.

This is a non-promotional CLL educational meeting for UK haemato-oncology healthcare professionals, fully funded and organised by the AstraZeneca UK Medical Affairs team.


Agenda
 

09:00—09:45

Registration and networking

09:45—10:00

Welcome and Introduction - Dr Wendy Osborne

10:00—11:15

Session 1: Integrated MDT approaches. Elevating patient care as a team - Dr Talha Munir, Ms Emily Mangan, Ms Rachel Senior

  • Understand how teamwork is associated with the quality and safety of care delivery
  • Explore actionable strategies for effective communication within an MDT and best practice guidance

11:15—11.30

Break

11:30—12.45

Session 2: Psychological Support for CLL Patients - Dr Sarah Noakes

  • Understand the principles of shared decision making, including considerations and challenges
  • Explore how shared decision making is implemented in clinical practice through the lens of a patient case study

12:45—13.30

Lunch break

13:30—14.15


14:15—15:00

Workshop 1 - Ms Hannah Miller, Ms Karen Stanley 

  • Pharmacist- and nurse-led clinics: Practicalities of patient-centric approaches

Workshop 2 - Ms Hannah Miller, Ms Karen Stanley

  • From data to diagnosis: Navigating clinical significances, the differences across district general hospitals and tertiary referral centres

15:00—15:15

Break

15:15—16.00

Meet the experts - Dr Wendy Osborne, Dr Cathy Burton

  • Bridging the gap from today to the future: Clinical significance of biomarkers in lymphoma

16:00—16.15

Closing words - Dr Wendy Osborne